Your session is about to expire
← Back to Search
Local Anesthetic
Buffered Anesthetic for Toothache
Phase 4
Recruiting
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between the ages of 18 and 80 years old
Have the ability and willingness to independently consent to treatment and study participation
Must not have
A radiographic periradicular pathosis more advanced than a widened periodontal ligament or have an intraoral swelling
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 20 minutes post-drug administration
Awards & highlights
No Placebo-Only Group
Drug Has Already Been Approved
Pivotal Trial
Summary
This trial compares two anesthetics to see which one numbs teeth faster and better.
Who is the study for?
This trial is for adults aged 18-80 with a toothache from irreversible pulpitis in a lower back tooth, who are generally healthy and not pregnant. Participants must not have allergies to local anesthetics or be on certain painkillers that could affect the study.
What is being tested?
The study tests if combining different numbing medicines (Articaine, Mepivacaine, Lidocaine with Sodium bicarbonate) works better for dental pain than using them separately. It also looks at how quickly they numb the affected nerve.
What are the potential side effects?
Possible side effects include temporary numbness beyond the targeted area, mild discomfort at injection site, allergic reactions to components of the anesthetic solution, and rare cases of prolonged numbness.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 80 years old.
Select...
I can and agree to make my own decisions about treatment and study participation.
Select...
I have lasting tooth pain in a lower back tooth when it's exposed to cold.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have a severe tooth root infection or swelling inside my mouth.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 20 minutes post-drug administration
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 20 minutes post-drug administration
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Visual analogue scale (VAS) Scores as Measures of Profoundness of Pulpal Anesthesia
Secondary study objectives
Onset of Pulpal Anesthesia
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Drug Has Already Been Approved
The FDA has already approved this drug, and is just seeking more data.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: BufferedExperimental Treatment4 Interventions
Buffered 2% lidocaine with 1:100,000 epinephrine Buffered 4% articaine with 1:100,000 epinephrine Buffered 3% mepivacaine Buffered local anesthetic (addition of sodium bicarbonate to make a 10% buffered solution)
Group II: UnbufferedActive Control3 Interventions
Unbuffered 2% lidocaine with 1:100,000 epinephrine Unbuffered 4% articaine with 1:100,000 epinephrine Unbuffered 3% mepivacaine Standard local anesthetics
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sodium bicarbonate
2012
Completed Phase 4
~3680
Find a Location
Who is running the clinical trial?
Indiana UniversityLead Sponsor
1,035 Previous Clinical Trials
1,218,919 Total Patients Enrolled
Kenneth Spolnik, DDSStudy ChairProgram Director
Share this study with friends
Copy Link
Messenger